ARCHIVES

Clinical Trials Approved By NCI

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation

November 13, 1992

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

March 1, 2002

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

Plans For NIH Women’s Health Study Discussed In Forum; $500 Mil. Program To Be Funded Through Contracts

November 8, 1991

No Cancer Letter For Next Two Weeks

August 19, 1994